Target- |
MechanismImmunostimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.China |
First Approval Date21 Oct 2011 |
100 Clinical Results associated with Changsheng Bio-Technology Co., Ltd.
0 Patents (Medical) associated with Changsheng Bio-Technology Co., Ltd.
100 Deals associated with Changsheng Bio-Technology Co., Ltd.
100 Translational Medicine associated with Changsheng Bio-Technology Co., Ltd.